Asymmetry Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-37,141	Closed	-$1.52M	–	35
2019 Q3	$1.52M	Sell	37,141 -60,358	-62%	-$2.47M	3.26%	14
2019 Q2	$4.59M	Buy	+97,499	New	+$4.59M	2.49%	16